Based on the Centene Corp stock forecast from 11 analysts, the average analyst target price for Centene Corp is USD 87.60 over the next 12 months. Centene Corp’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Centene Corp is Neutral, which is based on 7 positive signals and 7 negative signals. At the last closing, Centene Corp’s stock price was USD 60.35. Centene Corp’s stock price has changed by +2.85% over the past week, -1.07% over the past month and -18.68% over the last year.
No recent analyst target price found for Centene Corp
No recent average analyst rating found for Centene Corp
Company Overview Centene Corp
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri. Read Less
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segmen...Read More
Frequently Asked Questions About Centene Corp (CNC) Stock
Based on ratings from 11 analysts Centene Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 18 buy, sell and 7 hold ratings.
Unfortunately we do not have enough data on CNC's stock to indicate if its a good dividend stock.
Based on targets from 11 analysts, the average taret price for CNC is USD 87.60 over the next 12 months. The maximum analyst target price is USD 110 while the minimum anlayst target price is USD 68.
CNC stock's Price/Earning ratio is 10.39.
Our analysis grades CNC stock's Price / Earning ratio at A+. This means that CNC stock's Price/Earning ratio is above 0% of the stocks in the Healthcare Plans sector in the NYE exchange.
Based on this CNC may be undervalued for its sector.
The last closing price of CNC's stock was USD 60.35.
The most recent market capitalization for CNC is USD 30.37B.
Based on targets from 11 analysts, the average taret price for CNC is projected at USD 87.60 over the next 12 months.
This means that CNC's stock price may go up by +45.15% over the next 12 months.
We can't find any ETFs which contains Centene Corp's stock.
As per our most recent records Centene Corp has 67,700 Employees.
Centene Corp's registered address is Centene Plaza, Saint Louis, MO, United States, 63105.
You can get more information about it from Centene Corp's website at https://www.centene.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Underpriced on free cash flow basis
The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Frequently Asked Questions About Centene Corp (CNC) Stock
Based on ratings from 11 analysts Centene Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 18 buy, sell and 7 hold ratings.
Unfortunately we do not have enough data on CNC's stock to indicate if its a good dividend stock.
Based on targets from 11 analysts, the average taret price for CNC is USD 87.60 over the next 12 months. The maximum analyst target price is USD 110 while the minimum anlayst target price is USD 68.
CNC stock's Price/Earning ratio is 10.39.
Our analysis grades CNC stock's Price / Earning ratio at A+. This means that CNC stock's Price/Earning ratio is above 0% of the stocks in the Healthcare Plans sector in the NYE exchange.
Based on this CNC may be undervalued for its sector.
The last closing price of CNC's stock was USD 60.35.
The most recent market capitalization for CNC is USD 30.37B.
Based on targets from 11 analysts, the average taret price for CNC is projected at USD 87.60 over the next 12 months.
This means that CNC's stock price may go up by +45.15% over the next 12 months.
We can't find any ETFs which contains Centene Corp's stock.
As per our most recent records Centene Corp has 67,700 Employees.
Centene Corp's registered address is Centene Plaza, Saint Louis, MO, United States, 63105.
You can get more information about it from Centene Corp's website at https://www.centene.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for CNC !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
